Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi)

Sam Phiri(Lighthouse Trust), Mina C. Hosseinipour, Salem Gugsa(Office of the National Coordinator for Health Information Technology), Florence Kasende(Dignitas International), Frank Chimbwandira(Centers for Disease Control and Prevention), Erik J Schouten(Public Health Institute of Malawi), Clement Trapence(Lighthouse Trust), Levison Chiwaula(University of Malawi), Blessings N. Kaunda-Khangamwa(University of Malawi), Fabian Cataldo(Dignitas International), Monique van Lettow(University of Toronto), Hannock Tweya(International Union Against Tuberculosis and Lung Disease), Virginia Kayoyo, Atupele Kapito–Tembo(University of Malawi), Veena Sampathkumar(Christian Health Association of Malawi), Nora E. Rosenberg, Christopher Stanley, Michael Eliya(Ministry of Health)
JAIDS Journal of Acquired Immune Deficiency Syndromes
May 12, 2017
10.1097/qai.0000000000001357
Cited by 94

Related Papers

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
|AIDS|2014|375
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
|The Lancet HIV|2016|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|171
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|171